Braidwell LP
- SEC CIK
- 0001920938
- 最新申報
- 2026/8/14
2023 年第 1 季持倉
持倉截至 2023/3/31，2023/5/15 申報。只含多頭部位，變化是跟 2022 年第 4 季比股數。
- 持股檔數
- 81
- 較 2022 年第 4 季 −7
- 總值
- $30.3 億
- 較 2022 年第 4 季 +$4,788 萬 (+1.6%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| Guardant Health, Inc.40131MAB5 | NOTE 11/1 | – | $1.69 億 | 5.6% | – | – | – |
| Exact Sciences Corp30063PAC9 | NOTE 0.375% 3/0 | – | $1.23 億 | 4.0% | – | – | – |
| Nanostring Technologies Inc63009RAD1 | NOTE 2.625% 5/0 | – | $1.22 億 | 4.0% | – | – | – |
| NovoCure Ltd67011XAB9 | NOTE 11/0 | – | $1.17 億 | 3.9% | – | – | – |
| Alphatec Hldgs Inc02081GAB8 | NOTE 0.750% 8/0 | – | $1.08 億 | 3.6% | – | – | – |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $1.06 億 | 3.5% | – | – | – |
| Nevro Corp64157FAC7 | NOTE 2.750% 4/0 | – | $1.03 億 | 3.4% | – | – | – |
| GKOSGLAUKOS Corp | COM | 1,806,651 | $9,051 萬 | 3.0% | +144,800+8.7% | 加碼 | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 3,714,672 | $9,038 萬 | 3.0% | +373,372+11.2% | 加碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 766,800 | $7,762 萬 | 2.6% | +766,800 | 新進 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 2,137,110 | $7,649 萬 | 2.5% | +589,000+38.0% | 加碼 | 歷史 |
| ALGNAlign Technology Inc | COM | 207,130 | $6,921 萬 | 2.3% | −12,800−5.8% | 減碼 | 歷史 |
| BIIBBiogen Inc. | COM | 220,742 | $6,137 萬 | 2.0% | −31,800−12.6% | 減碼 | 歷史 |
| NVRONevro Corp | COM | 1,632,915 | $5,903 萬 | 1.9% | +440,617+37.0% | 加碼 | 歷史 |
| ISRGIntuitive Surgical Inc | COM NEW | 223,120 | $5,700 萬 | 1.9% | 00.0% | 不變 | 歷史 |
| IRTCiRhythm Holdings, Inc. | COM | 454,169 | $5,633 萬 | 1.9% | −43,498−8.7% | 減碼 | 歷史 |
| NTRANatera, Inc. | COM | 982,241 | $5,453 萬 | 1.8% | −638,771−39.4% | 減碼 | 歷史 |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $5,390 萬 | 1.8% | – | – | – |
| Nuvasive Inc670704AL9 | NOTE 1.000% 6/0 | – | $5,115 萬 | 1.7% | – | – | – |
| Karyopharm Therapeutics Inc.48576UAA4 | NOTE 3.000%10/1 | – | $5,115 萬 | 1.7% | – | – | – |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 3,241,351 | $5,008 萬 | 1.7% | −30,162−0.9% | 減碼 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 1,319,978 | $4,947 萬 | 1.6% | −42,300−3.1% | 減碼 | 歷史 |
| Ionis Pharmaceuticals Inc462222AD2 | NOTE 4/0 | – | $4,813 萬 | 1.6% | – | – | – |
| Exact Sciences Corp30063PAB1 | NOTE 0.375% 3/1 | – | $4,518 萬 | 1.5% | – | – | – |
| KIDSOrthopediatrics Corp | COM | 998,871 | $4,424 萬 | 1.5% | −45,828−4.4% | 減碼 | 歷史 |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 3,159,895 | $4,225 萬 | 1.4% | +1,913,356+153.5% | 加碼 | 歷史 |
| ENTAEnanta Pharmaceuticals Inc | COM | 1,038,310 | $4,199 萬 | 1.4% | +712,472+218.7% | 加碼 | 歷史 |
| Amyris, Inc.03236MAJ0 | NOTE 1.500%11/1 | – | $3,908 萬 | 1.3% | – | – | – |
| AMGNAmgen Inc | Stock | 161,500 | $3,904 萬 | 1.3% | +30,400+23.2% | 加碼 | 歷史 |
| INSMED Inc457669AA7 | NOTE 1.750% 1/1 | – | $3,649 萬 | 1.2% | – | – | – |
| Neogenomics Inc64049MAB6 | NOTE 0.250% 1/1 | – | $3,602 萬 | 1.2% | – | – | – |
| Ionis Pharmaceuticals Inc462222AB6 | NOTE 0.125%12/1 | – | $3,380 萬 | 1.1% | – | – | – |
| Nuvasive Inc670704AJ4 | NOTE 0.375% 3/1 | – | $3,247 萬 | 1.1% | – | – | – |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 2,019,714 | $3,244 萬 | 1.1% | −1,449,960−41.8% | 減碼 | 歷史 |
| OMOutset Medical, Inc. | COM | 1,754,350 | $3,228 萬 | 1.1% | +49,798+2.9% | 加碼 | 歷史 |
| Neogenomics Inc64049MAA8 | NOTE 1.250% 5/0 | – | $3,096 萬 | 1.0% | – | – | – |
| HROWHarrow, Inc. | COM | 1,452,538 | $3,074 萬 | 1.0% | +1,452,538 | 新進 | 歷史 |
| PENPenumbra Inc | COM | 107,044 | $2,983 萬 | 1.0% | −55,784−34.3% | 減碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 4,126,194 | $2,971 萬 | 1.0% | +13,700+0.3% | 加碼 | – |
| LEGNLegend Biotech Corp | SPONSORED ADS | 601,801 | $2,902 萬 | 1.0% | −56,300−8.6% | 減碼 | 歷史 |
| DICEDICE Therapeutics, Inc. | COM | 984,800 | $2,821 萬 | 0.9% | +145,725+17.4% | 加碼 | 歷史 |
| Travere Therapeutics, Inc.89422GAA5 | NOTE 2.250% 3/0 | – | $2,787 萬 | 0.9% | – | – | – |
| KRYSKrystal Biotech, Inc. | COM | 348,036 | $2,786 萬 | 0.9% | −10,020−2.8% | 減碼 | 歷史 |
| BridgeBio Pharma, Inc.10806XAD4 | NOTE 2.250% 2/0 | – | $2,738 萬 | 0.9% | – | – | – |
| MRUSMerus N.V. | COM | 1,473,084 | $2,710 萬 | 0.9% | −525,000−26.3% | 減碼 | 歷史 |
| HLVXHilleVax, Inc. | COM | 1,620,216 | $2,678 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 3,269,094 | $2,645 萬 | 0.9% | +875,109+36.6% | 加碼 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 1,997,055 | $2,365 萬 | 0.8% | +1,997,055 | 新進 | 歷史 |
| ANABAnaptysbio, Inc | COM | 973,073 | $2,117 萬 | 0.7% | +246,951+34.0% | 加碼 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 426,110 | $2,107 萬 | 0.7% | +426,110 | 新進 | 歷史 |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 12,107,785 | $2,046 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| ALECAlector, Inc. | COM | 3,206,315 | $1,985 萬 | 0.7% | +2,481,291+342.2% | 加碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 920,049 | $1,943 萬 | 0.6% | −322,753−26.0% | 減碼 | 歷史 |
| GMEDGlobus Medical Inc | Stock | 335,200 | $1,899 萬 | 0.6% | −8,426−2.5% | 減碼 | 歷史 |
| FNAParagon 28, Inc. | COM | 1,098,722 | $1,876 萬 | 0.6% | +1,098,722 | 新進 | 歷史 |
| STESTERIS plc | SHS USD | 95,694 | $1,830 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| MRTXMirati Therapeutics, Inc. | COM | 452,000 | $1,681 萬 | 0.6% | +38,400+9.3% | 加碼 | 歷史 |
| BCRXBiocryst Pharmaceuticals Inc | COM | 1,945,134 | $1,622 萬 | 0.5% | +1,945,134 | 新進 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 1,377,872 | $1,587 萬 | 0.5% | +624,727+82.9% | 加碼 | 歷史 |
| Invitae Corp46185LAB9 | NOTE 2.000% 9/0 | – | $1,484 萬 | 0.5% | – | – | – |
| VIRVir Biotechnology, Inc. | COM | 604,036 | $1,406 萬 | 0.5% | +604,036 | 新進 | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 3,355,805 | $1,379 萬 | 0.5% | +1,493,105+80.2% | 加碼 | 歷史 |
| LUNGPulmonx Corp | COM | 1,163,294 | $1,301 萬 | 0.4% | −458,200−28.3% | 減碼 | 歷史 |
| PACBPacific Biosciences of California, Inc. | COM | 1,097,300 | $1,271 萬 | 0.4% | +1,097,300 | 新進 | 歷史 |
| CMPXCompass Therapeutics, Inc. | COM | 3,247,847 | $1,062 萬 | 0.4% | +1,433,581+79.0% | 加碼 | 歷史 |
| ACLXArcellx, Inc. | COMMON STOCK | 333,800 | $1,028 萬 | 0.3% | +333,800 | 新進 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 24,600 | $916.5 萬 | 0.3% | −24,600−50.0% | 減碼 | 歷史 |
| AXNXAxonics, Inc. | COM | 166,704 | $909.5 萬 | 0.3% | +166,704 | 新進 | 歷史 |
| MLYSMineralys Therapeutics, Inc. | COM | 550,300 | $861.8 萬 | 0.3% | +550,300 | 新進 | 歷史 |
| TMDXTransMedics Group, Inc. | COM | 98,459 | $745.6 萬 | 0.2% | −204,726−67.5% | 減碼 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 4,122,900 | $684.4 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| Supernus Pharmaceuticals, Inc.868459AD0 | NOTE 0.625% 4/0 | – | $651.5 萬 | 0.2% | – | – | – |
| ADPTAdaptive Biotechnologies Corp | COM | 648,451 | $572.6 萬 | 0.2% | +648,451 | 新進 | 歷史 |
| ALXOAlx Oncology Holdings Inc | COM | 1,249,900 | $565.0 萬 | 0.2% | +991,620+383.9% | 加碼 | 歷史 |
| INSMED Inc457669AB5 | NOTE 0.750% 6/0 | – | $272.1 萬 | 0.1% | – | – | – |
| SILKSilk Road Medical Inc | COM | 63,331 | $247.8 萬 | 0.1% | −353,486−84.8% | 減碼 | 歷史 |
| IMTXImmatics N.V. | SHS | 322,287 | $222.4 萬 | 0.1% | −927,765−74.2% | 減碼 | 歷史 |
| ESPREsperion Therapeutics, Inc. | COM | 1,211,519 | $192.6 萬 | 0.1% | −2,181,886−64.3% | 減碼 | 歷史 |
| REPLReplimune Group, Inc. | COM | 73,665 | $130.1 萬 | <0.1% | −588,684−88.9% | 減碼 | 歷史 |
| Illumina, Inc.452327AK5 | NOTE 8/1 | – | $108.8 萬 | <0.1% | – | 新進 | – |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 247,254 | $43.3 萬 | <0.1% | +247,254 | 新進 | 歷史 |
2022 年第 4 季之後清倉（21 檔）
2022 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 4 季股數 | 2022 年第 4 季市值 | 2022 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | COM | 1,455,585 | $3,061 萬 | 1.0% | 歷史 |
| QDELQuidelOrtho Corp | COM | 300,437 | $2,574 萬 | 0.9% | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 1,493,121 | $2,377 萬 | 0.8% | 歷史 |
| Biomarin Pharmaceutical Inc09061GAK7 | NOTE 1.250% 5/1 | – | $2,073 萬 | 0.7% | – |
| APLSApellis Pharmaceuticals, Inc. | COM | 389,596 | $2,015 萬 | 0.7% | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 1,000,000 | $1,980 萬 | 0.7% | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 140,352 | $1,819 萬 | 0.6% | 歷史 |
| EWEdwards Lifesciences Corp | Stock | 235,319 | $1,756 萬 | 0.6% | 歷史 |
| IMGNImmunoGen, Inc. | COM | 3,474,497 | $1,723 萬 | 0.6% | 歷史 |
| COOCooper Companies, Inc. | COM NEW | 52,115 | $1,723 萬 | 0.6% | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 927,800 | $1,012 萬 | 0.3% | 歷史 |
| Biomarin Pharmaceutical Inc09061GAH4 | NOTE 0.599% 8/0 | – | $957.4 萬 | 0.3% | – |
| VRDNViridian Therapeutics, Inc. | COM | 313,403 | $915.5 萬 | 0.3% | 歷史 |
| NKTXNkarta, Inc. | COM | 1,525,800 | $914.0 萬 | 0.3% | 歷史 |
| ALLKAllakos Inc. | COM | 920,304 | $774.9 萬 | 0.3% | 歷史 |
| KODKodiak Sciences Inc. | COM | 914,209 | $654.6 萬 | 0.2% | 歷史 |
| FUSNFusion Pharmaceuticals Inc. | COM | 2,000,000 | $630.0 萬 | 0.2% | 歷史 |
| MISTMilestone Pharmaceuticals Inc. | COM | 1,164,849 | $461.3 萬 | 0.2% | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 381,120 | $400.2 萬 | 0.1% | 歷史 |
| NKTRNektar Therapeutics | COM | 620,280 | $140.2 萬 | <0.1% | 歷史 |
| ITOSiTeos Therapeutics, Inc. | COM | 71,585 | $139.8 萬 | <0.1% | 歷史 |